• DAPI (hydrochloride): From Stain to Translation

  2026-09-01

  Translational studies increasingly require quantitative links between biological mechanism and cellular outcome. This article examines how DAPI (hydrochloride), a DNA-specific fluorescent probe, can strengthen host–pathogen and biomaterials workflows inspired by an erythrocyte-mimicking nanovesicle strategy against Porphyromonas gingivalis—while clarifying what the dye can and cannot prove.

• 2X HyperFusion High-Fidelity Master Mix for CRISPR PCR

  2026-09-01

  Translate CRISPR immunotherapy concepts into dependable cloning, genotyping, and construct-validation workflows with high-accuracy DNA amplification. This guide combines practical cycling parameters, blunt-end cloning guidance, and troubleshooting for the 2X HyperFusion High-Fidelity Master Mix.

• Tiamulin Workflows for Infection and Inflammation

  2026-08-31

  Tiamulin (Thiamutilin) links strain-aware antibacterial testing with an emerging TNF-α inflammation workflow. This guide shows how to select concentrations, build controls, translate PK/PD benchmarks, and troubleshoot solubility, formulation, and assay-specific confounders.

• GS-441524: LC–MS/MS Workflow Guide

  2026-08-31

  Build more informative antiviral assays by separating parent GS-441524 from prodrug conversion products across gastric, blood, microsomal, and pharmacokinetic workflows. This practical guide combines LC–MS/MS planning, solvent handling, matrix controls, and troubleshooting for GS-441524 antiviral research.

• Clathrin-Mediated Entry of Grass Carp Reovirus

  2026-08-30

  Wang et al. used complementary inhibitor profiling, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated, acidified endosomal route. The study provides a useful mechanistic framework for aquatic virology while also illustrating how pharmacological perturbation can be combined with imaging and replication assays in endocytosis research.

• Oligomycin A for Mitochondrial Energy Workflows

  2026-08-29

  Oligomycin A provides a controlled way to separate ATP synthase failure from broader mitochondrial or ion-homeostasis defects. This article translates that selectivity into respiration, ROS, cancer metabolism, and sodium-overload workflows with practical preparation, dosing, and troubleshooting guidance.

• Tiamulin: From MIC to PK/PD Assay Design

  2026-08-28

  Tiamulin (Thiamutilin) is a pleuromutilin antibiotic whose value depends on linking ribosomal inhibition to susceptibility, exposure, and inflammatory endpoints. This guide presents a measurement-centered framework for designing defensible veterinary and translational assays.

• GSTA1 in α-Amanitin Hepatotoxicity

  2026-08-28

  A 2026 study identifies GSTA1 as an unexpected driver of α-amanitin-induced liver injury rather than a purely protective detoxification enzyme. By combining mouse toxicology, multi-omics, protein-interaction assays, and GSTA1 knockdown, the authors link NRF2-associated GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte injury.

• Cefotaxime for Resistance Research Workflows

  2026-08-27

  Cefotaxime provides a practical phenotypic tool for probing beta-lactam resistance, plasmid-associated selection, and bacterial infection model design. This guide connects assay setup, transmission-focused experiments, and troubleshooting to findings from carbapenem-resistant Enterobacter cloacae research.

• Tivozanib (AV-951): Measure Arrest vs Killing

  2026-08-27

  Tivozanib and AV-951 offer a precise model for studying VEGFR-driven cancer biology, but reduced viability does not automatically mean cell death. This article applies a phenotype-aware framework to anti-angiogenic therapy, helping researchers design assays that distinguish proliferative arrest, cytotoxicity, and pathway-specific response.

• NMDA in Excitotoxicity and Glaucoma Models

  2026-08-26

  NMDA (N-Methyl-D-aspartic acid) provides a direct, controllable way to activate NMDA receptors and connect early calcium influx with oxidative injury and neuronal loss. This guide translates a recent NMDA-based glaucoma study into practical workflows for excitotoxicity research, ferroptosis profiling, and retinal stem cell experiments.

• MVC Activates RhoA/ROCK1/MLC2 to Disrupt Tight Junctions

  2026-08-26

  A 2025 study identifies a direct interaction between the MVC capsid protein VP2 and the kinase domain of ROCK1, linking viral attachment to activation of the RhoA/ROCK1/MLC2 pathway. The resulting actomyosin contraction dissociates tight junctions, exposes occludin, and promotes MVC infection, providing a mechanistic framework for investigating antiviral intervention at the host-cell barrier.

• Patient-Derived Gastric Cancer Assembloids Explained

  2026-08-25

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine matched tumor organoids with stromal cell subpopulations from the same tumor. The model reveals how tumor–stroma interactions reshape gene expression and drug sensitivity, supporting more physiologically relevant cancer biology research and personalized drug-screening strategies.

• LY294002: PI3K Signaling and Research Use

  2026-08-25

  LY294002 is a reversible class I PI3K inhibitor that targets p110α, p110β, and p110δ through ATP-site binding. Its reported effects on Akt/mTOR signaling, apoptosis, autophagy, and tumor growth make it useful for pathway-dissection studies, including ovarian carcinoma research.

• Afatinib in Context-Rich Cancer Models

  2026-08-24

  Afatinib (BIBW 2992) can reveal how ErbB signaling behaves in patient-derived tumor–stroma systems. This article presents a context-aware framework for interpreting Afatinib responses in gastric cancer assembloids, with emphasis on assay design, resistance biology, and translational relevance.

7978 records 1/532 page Next 12345 下5页 Last page